Adhera Therapeutics ATRX Stock
Adhera Therapeutics Price Chart
Adhera Therapeutics ATRX Financial and Trading Overview
| Adhera Therapeutics stock price | 0.01 USD |
| Previous Close | 0.06 USD |
| Open | 0.06 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.04 - 0.06 USD |
| 52 Week Range | 0.04 - 1.9 USD |
| Volume | 61K USD |
| Avg. Volume | 11.08K USD |
| Market Cap | 174.47K USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.17 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ATRX Valuation Measures
| Enterprise Value | 9.79M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Adhera Therapeutics Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -96.42% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.9 USD |
| 52 Week Low | 0.04 USD |
| 50-Day Moving Average | 0.26 USD |
| 200-Day Moving Average | 0.71 USD |
ATRX Share Statistics
| Avg. Volume (3 month) | 11.08K USD |
| Avg. Daily Volume (10-Days) | 23.06K USD |
| Shares Outstanding | 3.49M |
| Float | 2.56M |
| Short Ratio | 3.24 |
| % Held by Insiders | 21.75% |
| % Held by Institutions | 0% |
| Shares Short | 2.05K |
| Short % of Float | 3.93% |
| Short % of Shares Outstanding | 3.91% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -938.86% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -3208000 USD |
| Diluted EPS (ttm) | -0.96 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 69K USD |
| Total Cash Per Share (mrq) | 0.02 USD |
| Total Debt (mrq) | 9.63M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.004 |
| Book Value Per Share (mrq) | -7.265 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1509000 USD |
| Levered Free Cash Flow (ttm) | -6473875 USD |
Profile of Adhera Therapeutics
| Country | United States |
| State | LA |
| City | Baton Rouge |
| Address | 8000 Innovation Parkway |
| ZIP | 70820 |
| Phone | 919 518 3748 |
| Website | https://adherathera.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 2 |
Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson's disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.
Q&A For Adhera Therapeutics Stock
What is a current ATRX stock price?
Adhera Therapeutics ATRX stock price today per share is 0.01 USD.
How to purchase Adhera Therapeutics stock?
You can buy ATRX shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Adhera Therapeutics?
The stock symbol or ticker of Adhera Therapeutics is ATRX.
Which industry does the Adhera Therapeutics company belong to?
The Adhera Therapeutics industry is Biotechnology.
How many shares does Adhera Therapeutics have in circulation?
The max supply of Adhera Therapeutics shares is 7.22M.
What is Adhera Therapeutics Price to Earnings Ratio (PE Ratio)?
Adhera Therapeutics PE Ratio is now.
What was Adhera Therapeutics earnings per share over the trailing 12 months (TTM)?
Adhera Therapeutics EPS is -1.17 USD over the trailing 12 months.
Which sector does the Adhera Therapeutics company belong to?
The Adhera Therapeutics sector is Healthcare.